Lipitor Lawsuits Approach 1,500 in South Carolina Litigation, Bernstein Liebhard LLP Reports

Share Article

The number of lawsuits alleging Lipitor diabetes complications continues to increase in the District of South Carolina, where a multidistrict litigation is underway.

Free Case Review
Our Firm is not surprised to see the number of Lipitor lawsuits in South Carolina federal court continue to increase.

Nearly 1,500 Lipitor lawsuits ( have now been filed in a federal litigation that includes claims over the cholesterol-lowering statin, Bernstein Liebhard LLP reports.

According to a Case List updated on December 15th, at least 1,478 cases are now pending in the U.S. District Court, District of South Carolina, where the proceeding is underway. Lipitor lawsuits centralized in this jurisdiction similarly allege new-onset Type 2 diabetes caused by the medication, which is used to lower cholesterol in conjunction with diet and exercise and is manufactured by Pfizer Inc. Plaintiffs in these cases similarly allege that the company’s failed to adequately warn about risks associated with Lipitor. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)

“Our Firm is not surprised to see the number of Lipitor lawsuits in South Carolina federal court continue to increase, as we continue to hear from individuals who were allegedly harmed by the statin medication,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs including Lipitor. The Firm is actively filing Lipitor lawsuits on behalf of patients who allegedly developed new-onset Type 2 diabetes after use of the cholesterol statin.

Lipitor Lawsuits

Lipitor lawsuits now filed in the District of South Carolina, as well as other U.S. courts have continued to mount since February 2012, when the U.S. Food and Drug Administration (FDA) mandated that the label for this and other statin medications be adjusted to include new information about their possible association with Type 2 diabetes. A month earlier, a study published in JAMA: Internal Medicine found that post-menopausal women on statins were at an increased risk of developing new-onset Type 2 diabetes.*

Type 2 diabetes patients who allegedly developed the disease due to their use of Lipitor may be entitled to compensation from Pfizer. To learn more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

*, JAMA Internal Medicine, January 23, 2012.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have ben able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website